Cerity Partners LLC Grows Position in STERIS plc (NYSE:STE)

Cerity Partners LLC lifted its stake in STERIS plc (NYSE:STE - Free Report) by 4.1% in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 71,335 shares of the medical equipment provider's stock after purchasing an additional 2,797 shares during the quarter. Cerity Partners LLC owned about 0.07% of STERIS worth $17,302,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of STE. West Coast Financial LLC boosted its stake in shares of STERIS by 2.8% during the 3rd quarter. West Coast Financial LLC now owns 1,640 shares of the medical equipment provider's stock worth $398,000 after purchasing an additional 45 shares during the period. Taylor Frigon Capital Management LLC increased its stake in STERIS by 0.8% in the second quarter. Taylor Frigon Capital Management LLC now owns 6,175 shares of the medical equipment provider's stock worth $1,356,000 after purchasing an additional 46 shares during the period. Mather Group LLC. boosted its stake in shares of STERIS by 7.6% during the second quarter. Mather Group LLC. now owns 763 shares of the medical equipment provider's stock valued at $172,000 after purchasing an additional 54 shares during the period. EverSource Wealth Advisors LLC grew its holdings in shares of STERIS by 16.5% in the first quarter. EverSource Wealth Advisors LLC now owns 402 shares of the medical equipment provider's stock worth $82,000 after purchasing an additional 57 shares during the last quarter. Finally, Waterloo Capital L.P. lifted its holdings in STERIS by 3.2% during the 2nd quarter. Waterloo Capital L.P. now owns 1,916 shares of the medical equipment provider's stock valued at $421,000 after buying an additional 59 shares in the last quarter. Institutional investors own 94.69% of the company's stock.

Insider Buying and Selling at STERIS

In related news, CFO Michael J. Tokich sold 23,332 shares of the stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $247.00, for a total transaction of $5,763,004.00. Following the sale, the chief financial officer now directly owns 42,930 shares of the company's stock, valued at approximately $10,603,710. This represents a 35.21 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. 1.14% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on STE. JMP Securities reiterated a "market outperform" rating and issued a $265.00 price target on shares of STERIS in a report on Monday, November 18th. Needham & Company LLC reissued a "hold" rating on shares of STERIS in a research report on Friday, November 8th. Stephens restated an "overweight" rating and issued a $260.00 price objective on shares of STERIS in a report on Thursday, November 7th. KeyCorp raised their target price on shares of STERIS from $255.00 to $265.00 and gave the company an "overweight" rating in a research report on Tuesday, September 3rd. Finally, Piper Sandler upgraded shares of STERIS from a "neutral" rating to an "overweight" rating and increased their price objective for the company from $230.00 to $260.00 in a research note on Thursday, October 24th. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, STERIS has an average rating of "Moderate Buy" and an average price target of $253.00.

STERIS Stock Performance

Shares of STE traded down $2.00 during trading hours on Tuesday, reaching $214.12. 189,893 shares of the company traded hands, compared to its average volume of 497,125. The company has a quick ratio of 1.55, a current ratio of 2.41 and a debt-to-equity ratio of 0.33. The business has a fifty day moving average price of $226.73 and a 200-day moving average price of $228.69. STERIS plc has a 12-month low of $195.47 and a 12-month high of $248.24. The stock has a market capitalization of $21.14 billion, a P/E ratio of 49.35 and a beta of 0.85.

STERIS (NYSE:STE - Get Free Report) last released its earnings results on Wednesday, November 6th. The medical equipment provider reported $2.14 EPS for the quarter, topping analysts' consensus estimates of $2.12 by $0.02. STERIS had a return on equity of 13.78% and a net margin of 8.02%. The firm had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.33 billion. During the same quarter in the previous year, the company posted $2.03 earnings per share. The company's revenue was up 7.3% compared to the same quarter last year. Equities analysts anticipate that STERIS plc will post 9.15 EPS for the current fiscal year.

STERIS Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 19th. Investors of record on Tuesday, November 19th will be given a dividend of $0.57 per share. The ex-dividend date is Tuesday, November 19th. This represents a $2.28 dividend on an annualized basis and a yield of 1.06%. STERIS's dividend payout ratio is presently 52.05%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.